Edinburgh Worldwide Investment Trust plc announced the appointment of Ms. Jane McCracken as a non-executive Director of the Company with effect from 1 November 2022 and Dr. Mary Gunn as a non-executive Director of the Company with effect from 1 March 2023. Ms. JaneMcCracken has spent her career working with high growth technology businesses based in the USA and UK as an entrepreneur, equity investor, board member and advisor. Her experience covers a variety of areas including enterprise software, e-commerce, fintech, digital health and clinical research.

Most recently, she served as a Research Faculty member and Entrepreneur-in-Residence at the Georgia Institute of Technology in Atlanta, Georgia, USA and currently is the Chief Growth Officer for Corps Team LLC. She is also a non-executive director of Radyus Research LLC. Dr. Mary Gunn is a scientist, lawyer and C-level executive in life science companies, including previously at Pfizer, Crucell, ICON Plc and Health Decisions.

She also served on the boards and advisories of Brown University, Modelis, Lumiio and SpotArt Foundation. She is currently an Independent Director of Welwaze Medical and the President of RemRem LLC, a value creation advisory for investors, banks and entrepreneurs in clinical research and life science. The appointment of Ms McCrackenand Dr. Gunnfall to be ratified byshareholders at the Annual General Meeting of the Company to be held in March 2023.

As commented on in the 31 October 2021 Annual Report and Financial Statements Mr. Donald Cameron will not be standing for re-election at the Annual General Meeting to be held in March 2023.